Trials / Completed
CompletedNCT02337816
Role of Metabolomics in the Diagnosis of Endometriosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- University of Cagliari · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years. Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease. Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | laparoscopic surgery, obtainment of biological samples |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2015-01-14
- Last updated
- 2018-11-06
Source: ClinicalTrials.gov record NCT02337816. Inclusion in this directory is not an endorsement.